Three-year clinical outcomes of left atrial appendage occlusion with or without ablation: insight from the RECORD study
Europace · 2026
DOI: 10.1093/europace/euag022 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Europace, 2026. Verfasst von Tingting Zhang und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Xijing Hospital, The Fourth Military Medical University, Changle west road, Xi'an 710032, China. Hauptthemen laut MEDLINE: Atrial Appendage, Atrial Fibrillation, Catheter Ablation, Left Atrial Appendage Closure. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Boston Scientific Corporation.
Abstract (Originalsprache)
Aims
The long-term impact of left atrial appendage occlusion (LAAO) plus ablation for atrial fibrillation remains controversial. The present study aims to compare the three-year clinical outcomes of LAAO patients with or without one-staged ablation. Methods and results The RECORD study (NCT03917563) was a prospective registry conducted in 39 participating sites in China between 1 April 2019 and 31 October 2020, which consecutively enrolled 3082 patients who successfully received the WATCHMAN LAAO device. The current study compared patients who received LAAO only to patients who underwent LAAO plus ablation. A 1:1 propensity score matching was performed to attenuate confounding. The primary outcome was a composite endpoint of cardiovascular death, stroke, and systemic embolism at 3-year. 1633/2928 (55.8%) patients received LAAO only and 1295/2928 (44.2%) received LAAO plus ablation. After propensity score matching, 1016/2032 (50.0%) were in the LAAO group and 1016/2032 (50.0%) in the LAAO plus ablation group. The mean ± SD age was 68.8 ± 9.3 years, with 815 (40.1%) participants being female. The mean ± SD CHA2DS2-VASc and HAS-BLED scores at baseline were 3.9 ± 1.8 and 2.4 ± 1.1, respectively. At three-year, compared to LAAO only, LAAO plus ablation was associated with a lower risk of cardiovascular death, stroke, systemic embolism (6.9%vs.10.4%, HRPSM:0.66, 95%CI: 0.49–0.89, P = 0.007), which was driven mainly by the lower risk of cardiovascular death (3.7% vs. 7.3%, HRPSM: 0.50, 95%CI: 0.34–0.74, P = 0.001). No significant between-group differences were noted for BARC-defined bleeding.
Conclusion
LAAO plus ablation was associated with a lower risk of a composite of cardiovascular death, stroke, and systemic embolism than LAAO only at 3-year. However, given the observational nature of the current study, the results should be considered as hypothesis-generating only.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Xijing Hospital, The Fourth Military Medical University, Changle west road, Xi'an 710032, China.
- Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Lujiang road, Hefei 230001, China.
- Department of Cardiology, Changhai Hospital, Navy Military Medical University, Shanghai, China.
- Department of Cardiology, Arrhythmia Center, Ningbo First Hospital, Ningbo, China.
- Department of Cardiology, Taizhou People's Hospital, Taizhou, China.
- Department of Cardiology, Zhuhai Hospital Affiliated with Jinan University (Zhuhai People's Hospital), Zhuhai, China.
ORCID-Profile: Tingting Zhang, Guotao Fu, Jianzheng Liu, Ping Wang, Xianxian Zhao, Huimin Chu, Zhongbao Ruan, Xiaofei Jiang, Yansong Guo, Haixiong Wang, Chenyang Jiang, Shijun Li, Scot Garg, Osama Soliman, Patrick W Serruys, Chao Gao, Ling Tao
Förderung
- Boston Scientific Corporation
Zitieren
APA
Zhang, T., He, X., Fu, G., Liu, H., Yi, F., Liu, J., Wang, P., Chen, Z., Zhao, X., Chu, H., Ruan, Z., Jiang, X., Shen, C., Guo, Y., Wang, Z., Bai, M., Yuan, Y., Wang, H., Jiang, C., …, & Tao, L. (2026). Three-year clinical outcomes of left atrial appendage occlusion with or without ablation: insight from the RECORD study. Europace. https://doi.org/10.1093/europace/euag022
Vancouver
Zhang T, He X, Fu G, Liu H, Yi F, Liu J, et al. Three-year clinical outcomes of left atrial appendage occlusion with or without ablation: insight from the RECORD study. Europace. 2026. doi:10.1093/europace/euag022
BibTeX
@article{Zhang2026,
author = {Zhang, Tingting and He, Xueni and Fu, Guotao and Liu, Haitao and Yi, Fu and Liu, Jianzheng and Wang, Ping and Chen, Zhengquan and Zhao, Xianxian and Chu, Huimin and Ruan, Zhongbao and Jiang, Xiaofei and Shen, Chengxing and Guo, Yansong and Wang, Zulu and Bai, Ming and Yuan, Yiqiang and Wang, Haixiong and Jiang, Chenyang and Li, Shijun and Garg, Scot and Soliman, Osama and Serruys, Patrick W and Gao, Chao and Tao, Ling},
title = {Three-year clinical outcomes of left atrial appendage occlusion with or without ablation: insight from the RECORD study},
journal = {Europace},
year = {2026},
doi = {10.1093/europace/euag022}
}
EUVIMED